ACB
Price
$4.86
Change
-$0.09 (-1.82%)
Updated
Sep 26 closing price
Capitalization
273.14M
39 days until earnings call
CPIX
Price
$3.09
Change
+$0.06 (+1.98%)
Updated
Sep 26 closing price
Capitalization
46.23M
44 days until earnings call
Interact to see
Advertisement

ACB vs CPIX

Header iconACB vs CPIX Comparison
Open Charts ACB vs CPIXBanner chart's image
Aurora Cannabis
Price$4.86
Change-$0.09 (-1.82%)
Volume$670.28K
Capitalization273.14M
Cumberland Pharmaceuticals
Price$3.09
Change+$0.06 (+1.98%)
Volume$12.93K
Capitalization46.23M
ACB vs CPIX Comparison Chart in %
Loading...
ACB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CPIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACB vs. CPIX commentary
Sep 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACB is a StrongBuy and CPIX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 28, 2025
Stock price -- (ACB: $4.86 vs. CPIX: $3.09)
Brand notoriety: ACB: Notable vs. CPIX: Not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: ACB: 48% vs. CPIX: 26%
Market capitalization -- ACB: $273.14M vs. CPIX: $46.23M
ACB [@Pharmaceuticals: Generic] is valued at $273.14M. CPIX’s [@Pharmaceuticals: Generic] market capitalization is $46.23M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACB’s FA Score shows that 0 FA rating(s) are green whileCPIX’s FA Score has 0 green FA rating(s).

  • ACB’s FA Score: 0 green, 5 red.
  • CPIX’s FA Score: 0 green, 5 red.
According to our system of comparison, CPIX is a better buy in the long-term than ACB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACB’s TA Score shows that 4 TA indicator(s) are bullish while CPIX’s TA Score has 3 bullish TA indicator(s).

  • ACB’s TA Score: 4 bullish, 4 bearish.
  • CPIX’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, ACB is a better buy in the short-term than CPIX.

Price Growth

ACB (@Pharmaceuticals: Generic) experienced а -4.52% price change this week, while CPIX (@Pharmaceuticals: Generic) price change was -1.90% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -1.16%. For the same industry, the average monthly price growth was +24.25%, and the average quarterly price growth was +66.99%.

Reported Earning Dates

ACB is expected to report earnings on Nov 06, 2025.

CPIX is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (-1.16% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACB($273M) has a higher market cap than CPIX($46.2M). CPIX YTD gains are higher at: 30.380 vs. ACB (14.353). ACB has higher annual earnings (EBITDA): 26.6M vs. CPIX (3.49M). ACB has more cash in the bank: 140M vs. CPIX (16.1M). CPIX has less debt than ACB: CPIX (10.3M) vs ACB (102M). ACB has higher revenues than CPIX: ACB (358M) vs CPIX (42.1M).
ACBCPIXACB / CPIX
Capitalization273M46.2M591%
EBITDA26.6M3.49M762%
Gain YTD14.35330.38047%
P/E Ratio21.12N/A-
Revenue358M42.1M850%
Total Cash140M16.1M870%
Total Debt102M10.3M990%
FUNDAMENTALS RATINGS
ACB vs CPIX: Fundamental Ratings
ACB
CPIX
OUTLOOK RATING
1..100
6684
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
100
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9395
PRICE GROWTH RATING
1..100
5845
P/E GROWTH RATING
1..100
80100
SEASONALITY SCORE
1..100
85n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ACB's Valuation (58) in the Pharmaceuticals Other industry is somewhat better than the same rating for CPIX (100). This means that ACB’s stock grew somewhat faster than CPIX’s over the last 12 months.

ACB's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as CPIX (100). This means that ACB’s stock grew similarly to CPIX’s over the last 12 months.

ACB's SMR Rating (93) in the Pharmaceuticals Other industry is in the same range as CPIX (95). This means that ACB’s stock grew similarly to CPIX’s over the last 12 months.

CPIX's Price Growth Rating (45) in the Pharmaceuticals Other industry is in the same range as ACB (58). This means that CPIX’s stock grew similarly to ACB’s over the last 12 months.

ACB's P/E Growth Rating (80) in the Pharmaceuticals Other industry is in the same range as CPIX (100). This means that ACB’s stock grew similarly to CPIX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACBCPIX
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
81%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
85%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
83%
Advances
ODDS (%)
Bullish Trend 13 days ago
79%
Bullish Trend 17 days ago
80%
Declines
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 12 days ago
79%
BollingerBands
ODDS (%)
N/A
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
67%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ACB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CPIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CURI5.350.17
+3.28%
CuriosityStream
CFLT19.790.54
+2.81%
Confluent
DFIN51.450.64
+1.26%
Donnelley Financial Solutions
SCYX1.08-0.01
-0.46%
SCYNEXIS
KO65.67-0.31
-0.47%
Coca-Cola Company

ACB and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACB has been loosely correlated with CGC. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if ACB jumps, then CGC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACB
1D Price
Change %
ACB100%
-1.82%
CGC - ACB
64%
Loosely correlated
-2.19%
OGI - ACB
63%
Loosely correlated
-3.43%
CRON - ACB
54%
Loosely correlated
-0.38%
TLRY - ACB
53%
Loosely correlated
-3.36%
PAHC - ACB
31%
Poorly correlated
+2.02%
More

CPIX and

Correlation & Price change

A.I.dvisor tells us that CPIX and QNTM have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CPIX and QNTM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CPIX
1D Price
Change %
CPIX100%
+2.15%
QNTM - CPIX
26%
Poorly correlated
-4.39%
ACB - CPIX
22%
Poorly correlated
-1.82%
ELAN - CPIX
21%
Poorly correlated
+3.65%
PAHC - CPIX
21%
Poorly correlated
+2.02%
BGM - CPIX
20%
Poorly correlated
-0.20%
More